- Ut imperdiet leo id lorem fermentum consectetur.
- Ut vitae orci et dui varius tincidunt.
- Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Marketing & Strategy
Customer-Centric Engagement During COVID-19

Navigating the multichannel maze in COVID 19 times to engage healthcare professionals (HCPs) and patients has been challenging for most local marketing, medical and commercial teams.
In the last few weeks, Health Industry Hub gained insights from several clinicians (GPs, specialists and surgeons) on how the COVID-19 pandemic has impacted their day-to-day world in clinics and with their patients. See infographic below.
In overwhelming times, most HCPs are not looking to engage with the field force in one-on-one virtual meetings or phone calls unless there is a compelling reason to do so, for example, clinical trials, virtual advisory boards, new registration / reimbursement of medicines or medical devices.
Instead, HCPs are interested in receiving valuable, cross-functional medical content that is easy to access and is of benefit to them and/or their patients.
Click on the image below to learn more.

Customer engagement during COVID-19. Fill the gap of reduced field force activities. Health Industry Hub combines expertise in delivering digital health content and measuring engagement with 20+ years industry experience. Created by industry for industry. Contact us.
Leadership & Management

The power of being an authentic leader
Leadership & Management: Welcome to Health Industry Hub’s Women in Leadership Series – connecting, engaging and empowering women in the […]
MoreDigital & Innovation

Data is the biggest challenge, and opportunity, for MedTech
Digital & Innovation: Medical technology is increasingly shaping the future of healthcare. The sector is also a growing part of […]
MoreNews & Trends - Medical Technology

Thermo Fisher acquisition to better serve its pharma and biotech clients
MedTech News: Thermo Fisher Scientific is buying clinical research services provider PPD for a hearty $17.4 billion, and that’s not its only acquisition this […]
MoreNews & Trends - Pharmaceuticals

First-in-class oncology drug candidate licensed by Aussie pharma
Pharma News: An Australian oncology-focused drug development company entered into a worldwide exclusive licensing agreement and a master services agreement […]
More